Proteasome inhibitors in myeloma
Proteasome inhibitor drugs are a class of drug used to treat myeloma and include bortezomib (Velcade®) as well as other drugs in clinical trial and development including carfilzomib (Kyprolis®) and ixazomib (Ninlaro®). This animation explains how they work and why they are effective in treating myeloma.
Use Case
Type
Source
You might also like
CAR-T treatment in myeloma
Learn about CAR-T cell therapy, a cutting-edge immunotherapy that uses a patient’s own modified immune cells to treat myeloma.
Myeloma UK AnimationImmunotherapy in myeloma
This animation explains how the immune system functions and demonstrates its potential in treating myeloma.
Myeloma UK AnimationHigh Dose Therapy and Autologous stem cell transplantation
High-dose therapy and autologous stem cell transplantation is the standard treatment for younger or fitter myeloma patients. This animation outlines the stages of the procedure and the principles guiding each step.
Myeloma UK Animation